| The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib | |
| Wang, Wen-Quan; Liu, Liang; Xu, Hua-Xiang; Sun, Hui-Chuan; Wu, Chun-Tao; Zhu, Xiao-Dong; Zhang, Wei; Xu, Jin; Liu, Chen; Long, Jiang | |
| 刊名 | ONCOTARGET
 |
| 2014 | |
| 卷号 | 5期号:11 |
| 关键词 | HTATIP2 microvessel density sorafenib hepatocellular carcinoma prognosis |
| ISSN号 | 1949-2553 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4885850 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Wang, Wen-Quan,Liu, Liang,Xu, Hua-Xiang,et al. The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib[J]. ONCOTARGET,2014,5(11). |
| APA | Wang, Wen-Quan.,Liu, Liang.,Xu, Hua-Xiang.,Sun, Hui-Chuan.,Wu, Chun-Tao.,...&Yu, Xian-Jun.(2014).The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib.ONCOTARGET,5(11). |
| MLA | Wang, Wen-Quan,et al."The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib".ONCOTARGET 5.11(2014). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论